N/A N=78 Salivary and Serum Leptin Levels in Oral Lichen Planus Patients: A Case-control Study.
Oral Lichen Planus · Leptin Levels
Primary: Serum Leptin Level — 13.23; 4.20 ng/ml
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=120 Laser Lithotripsy During URS - Holmium vs Thulium
Urolithiasis
Primary: Stone Free Rate — 34; 47 Participants — p=<0.006
N/A N=178 Study 3 Learning Verbs and Pronouns
Autism Spectrum Disorder
Primary: Object Preference for Verbs — 0.57; 0.56 proportion of time — p=0.085
Phase 2 N=103 Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder
Autism Spectrum Disorder
Primary: Change From Baseline in Aberrant Behavior Checklist (ABC) Subscale Total Scores — -6.35; -5.41; -6.67; -8.05 score on a scale — p==0.085
Phase 2 N=24 Cabozantinib in Patients With Hepatocellular Carcinoma (ACTION)
Hepatocellular Carcinoma
Primary: Rate of Adverse Events (AE) ≥ Grade 3 (CTCAE 5.0) Excluding Palmar-plantar Erythrodysesthesia — 16 Participants
N/A N=141 A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic Arthritis
Psoriatic Arthritis
Primary: Change From Baseline to 6 Months in Tender Joint Count (68) — -2.5; -3.2; -2.0 Tender joints
N/A N=930 Resident-to-Resident Elder Mistreatment Intervention for Dementia Care in Assisted Living
Assisted Living, Resident to Resident Elder Mistreatment
Primary: Falls, Accidents, and Injuries — 141; 115 participants — p=0.4170
Phase 4 N=101 Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus
Diabetes Mellitus, Type 2 · Coronary Artery Disease
Primary: P2Y12 Reaction Units (PRU) — 47; 136; 39 PRU
N/A N=70 Building Habits Together Online Weight Loss Program
Obesity
Primary: Mobile App Use — 18; 33 days out of 168 total
N/A N=5,279 A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway.
Non-Small Cell Lung Cancer
Primary: Duration of Treatment of Anti-cancer Drugs — 11; 14; 9.4; 15.8 Months
Phase 3 N=41 A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis
Atopic Dermatitis (AD)
Primary: Success Rate in IGA (Percentage of Subjects With an IGA Score of 0 or 1 With Improvement by at Least 2 Grades) — 56.10 Percentage of perticipants
Phase 1 N=450 A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy Participants
Healthy
Primary: Pharmacokinetics (PK): Maximum Concentration (Cmax) of Mirikizumab in a Citrate-free Solution Formulation Compared to the Solution Formulation — 20.9; 20.9 micrograms…
Phase 2 N=59 A Novel Wearable Device to Improve Sleep Quality
Insomnia
Primary: Insomnia Symptoms — -7.34; -7.58 score on a scale — p=.88
N/A N=23 Train Your Brain: A Pilot Project to Improve Memory and Decision Making
Behavior, Health
Primary: Number of Participants With Change in Delay Discounting 5 Trial Adjusted Measure — 3 Participants
N/A N=26 Evaluating the Efficacy of the Mediterranean Diet to the Low- Fermentable, Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Diet in Treating Irritable Bowel Syndrome(IBS)
Irritable Bowel Syndrome
Primary: Proportion of Participants Who Are Responders Based on the Abdominal Pain Intensity Score for at Least 2 of 4 Weeks — 9; 8 Participants — p=1.00